Research & Development
Advancing the science that powers next-generation radiopharmaceuticals
At Telix, R&D powers our future — strengthening our capabilities and working across the business to advance assets from discovery to clinical proof-of-concept and deliver first- and best-in-class theranostics.
From bench to bedside, the team is driving new clinical applications, workflow innovations, and manufacturing advancements to develop imaging agents and therapies that have the potential to transform how cancer is detected, monitored and treated.
Core Innovation Pillars
.
Physical Sciences
Advancing applied chemistry and physics for next-generation radiopharmaceutical development
Our Physical Sciences team advances the foundational research that enables cutting-edge radiopharmaceutical development. Through precision science and innovation, the group provides the building blocks for transformative imaging and therapeutic agents within Telix’s global pipeline.
Drug Discovery
Driving breakthroughs in cancer biology through multidisciplinary research
Our Drug Discovery team pioneers novel theranostic strategies by investigating new approaches in molecular targeting, radiobiology, and immuno-oncology. Supported by Telix Targeting Technology’s engineered antibody platform and a state-of-the-art California research facility, we are accelerating the development of next-generation radiopharmaceuticals by evaluating the best targets for each disease state.
MedTech
Advancing AI-driven imaging and surgical innovation
Our MedTech division develops technologies that enhance both precision medicine and surgical care. The SENSEI® radio-guided surgery platform and related detection technologies are extending our targeting science into the operating room to improve surgical precision and patient outcomes. We are also exploring artificial intelligence to improve imaging analysis and support better informed clinical decisions.
Non-clinical
Driving safe, compliant, and efficient drug development for global impact
Our Non-Clinical team bridges discovery and development, ensuring scientific innovation progresses safely and efficiently toward clinical and commercial outcomes. Through a combination of regulatory expertise and translational science, they guide programs through complex pathways to deliver therapies to patients worldwide, with integrity and speed.
Partnership Opportunities
We are actively exploring partnership opportunities across our R&D programs and technology platforms.
To discuss collaboration or learn more about how we can work together, please contact us.
